Myeloid Disease with the CSF3R T618I Mutation after CLL

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• Chronic lymphocytic leukemia (CLL) is typically indolent, but patients face an increased risk of secondary malignancies, including rare myeloid neoplasms.
• The development of secondary hematological malignancies in CLL patients requires careful monitoring and investigation.

Observation:

• A 58-year-old male with CLL developed autoimmune hemolytic anemia, followed by neutrophilia, thrombocytopenia, and splenomegaly.
• Bone marrow examination revealed a chronic myeloproliferative disease without dysplasia.
• Genetic analysis identified the CSF3R T618I mutation in peripheral blood.

Findings:

• The presence of the CSF3R T618I mutation is a diagnostic criterion for Chronic Neutrophilic Leukemia (CNL).
• While CNL is strongly suggested, the patient's presentation also raised consideration for Chronic Myelomonocytic Leukemia (CMML).
• This case represents the first reported instance of potential CNL arising in a patient with a prior CLL diagnosis.

Implications:

• This case highlights the complex interplay between different myeloid malignancies and CLL.
• Further research is needed to understand the pathogenesis and optimal management of concurrent or sequential myeloid neoplasms in CLL patients.
• The identification of specific mutations like CSF3R T618I is crucial for accurate diagnosis and potential targeted therapies.